Introduction to Translating Orthobiologics and Cellular Therapies for the Musculoskeletal Provider

View at publisher Summarise with VIRAT
Authors: Shannon R. Strader, Michael Medlyn, Monica Klein, Margaret A. DiGuardo, Jennifer R. Arthurs, Shane Adam Shapiro
Cited by: 0
References: 13

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ABSTRACT: Within the field of regenerative medicine for musculoskeletal regenerative medicine, orthobiologics and cellular therapies are evolving at a rapid pace. Exuberant ideas for new treatments often outpace their scientific evidence, which may create confusion for both patients and providers on what treatments are evidence based. Orthobiologics and cellular therapies are a subset of regenerative therapies focused on treatment of musculoskeletal disease. For the field of orthobiologics to progress, it is essential that musculoskeletal providers understand the necessary components for translating novel therapies from discovery into practice. In this article, we provide an overview of both the lexicon and regulatory processes related to translation of orthobiologics and cellular therapies along with a comparison of how to translate orthobiologics and related novel cellular therapies in hopes to dispel misinformation while promoting responsible advancements and ethical practices in medicine.

Fields of Study & Subjects

Periodontal Regeneration and Treatments Biomedical Ethics and Regulation Mesenchymal stem cell research

Publication details

Journal / source
American Journal of Physical Medicine & Rehabilitation
Volume
105
Issue
4
Pages
363–369
Publication date
30 March 2026
Language
EN